Sandra L. Rodriguez-Guerrero
Mexico City, DIF, Mexico
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Identification of New CD36 Antagonists by Structure-Based Virtual Screening.
Journal: Chemical biology & drug design
Published: March 07, 2025
Discovery and in vitro characterization of a human anti-CD36 scFv.
Journal: Frontiers in immunology
Published: November 19, 2024
Continuous exposure to doxorubicin induces stem cell-like characteristics and plasticity in MDA-MB-231 breast cancer cells identified with the SORE6 reporter.
Journal: Cancer chemotherapy and pharmacology
Published: April 20, 2024
Role of CD36 in cancer progression, stemness, and targeting.
Journal: Frontiers in cell and developmental biology
Published: October 25, 2022
Targeting effector pathways in RAC1P29S-driven malignant melanoma.
Journal: Small GTPases
Published: February 12, 2020
Gpn3 Is Essential for Cell Proliferation of Breast Cancer Cells Independent of Their Malignancy Degree.
Journal: Technology in cancer research & treatment
Published: August 22, 2019
Transcriptome-based identification of lovastatin as a breast cancer stem cell-targeting drug.
Journal: Pharmacological reports : PR
Published: August 07, 2018
CCR5 Governs DNA Damage Repair and Breast Cancer Stem Cell Expansion.
Journal: Cancer research
Published: April 07, 2017
Virtual screening-driven repositioning of etoposide as CD44 antagonist in breast cancer cells.
Journal: Oncotarget
Published: December 22, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026